These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22728614)

  • 1. Insulin pump treatment in children and adolescents with type 1 diabetes.
    Hofer S; Meraner D; Koehle J
    Minerva Pediatr; 2012 Aug; 64(4):433-8. PubMed ID: 22728614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes.
    Karges B; Schwandt A; Heidtmann B; Kordonouri O; Binder E; Schierloh U; Boettcher C; Kapellen T; Rosenbauer J; Holl RW
    JAMA; 2017 Oct; 318(14):1358-1366. PubMed ID: 29049584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin pumps in pediatric routine care improve long-term metabolic control without increasing the risk of hypoglycemia.
    Hanas R; Adolfsson P
    Pediatr Diabetes; 2006 Feb; 7(1):25-31. PubMed ID: 16489971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus: decreased HbA1c with low risk of hypoglycemia.
    Sulli N; Shashaj B
    J Pediatr Endocrinol Metab; 2003 Mar; 16(3):393-9. PubMed ID: 12705364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
    Pala L; Dicembrini I; Mannucci E
    Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the timing of insulin pump therapy initiation after type 1 diabetes onset have an impact on glycemic control?
    Shalitin S; Lahav-Ritte T; Lebenthal Y; Devries L; Phillip M
    Diabetes Technol Ther; 2012 May; 14(5):389-97. PubMed ID: 22283639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Threshold-based insulin-pump interruption for reduction of hypoglycemia.
    Bergenstal RM; Klonoff DC; Garg SK; Bode BW; Meredith M; Slover RH; Ahmann AJ; Welsh JB; Lee SW; Kaufman FR;
    N Engl J Med; 2013 Jul; 369(3):224-32. PubMed ID: 23789889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the effectiveness of long-term insulin pump therapy using a combined goal of HbA
    Quirós C; Viñals C; Giménez M; Roca D; Conget I
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Nov; 66(9):534-539. PubMed ID: 31133475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
    Jarosz-Chobot P
    Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
    Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
    Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of depressive symptoms in well-controlled adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion.
    Zduńczyk B; Sendela J; Szypowska A
    Diabetes Metab Res Rev; 2014 May; 30(4):333-8. PubMed ID: 24323887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes.
    Boland EA; Grey M; Oesterle A; Fredrickson L; Tamborlane WV
    Diabetes Care; 1999 Nov; 22(11):1779-84. PubMed ID: 10546007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Guidelines concerning insulin dosage in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion].
    Szypowska A; Pańkowska E; Lipka M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):45-50. PubMed ID: 16704861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Impact of Prolonged Use of Continuous Subcutaneous Insulin Infusion in the Control of Type-1 Diabetes].
    Azevedo S; Saraiva J; Caramelo F; Fadiga L; Barros L; Baptista C; Melo M; Gomes L; Carrilho F
    Acta Med Port; 2019 Feb; 32(1):17-24. PubMed ID: 30753799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous Subcutaneous Insulin Infusion in Adult Type 1 Diabetes Mellitus Patients: Results from a Public Health System.
    Moreno-Fernandez J; Gomez FJ; Pinés P; González J; López J; López LM; Blanco B; Roa C; Herranz S; Muñoz-Rodríguez JR
    Diabetes Technol Ther; 2019 Aug; 21(8):440-447. PubMed ID: 31199682
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin pump therapy in children and adolescents: improvements in key parameters of diabetes management including quality of life.
    McMahon SK; Airey FL; Marangou DA; McElwee KJ; Carne CL; Clarey AJ; Davis EA; Jones TW
    Diabet Med; 2005 Jan; 22(1):92-6. PubMed ID: 15606698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does treatment with an insulin pump improve glycaemic control in children and adolescents with type 1 diabetes? A retrospective case-control study.
    Brorsson AL; Viklund G; Örtqvist E; Lindholm Olinder A
    Pediatr Diabetes; 2015 Nov; 16(7):546-53. PubMed ID: 25327782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin Pump Therapy.
    Nimri R; Nir J; Phillip M
    Am J Ther; 2020; 27(1):e30-e41. PubMed ID: 31833871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion.
    Weintrob N; Schechter A; Benzaquen H; Shalitin S; Lilos P; Galatzer A; Phillip M
    Arch Pediatr Adolesc Med; 2004 Jul; 158(7):677-84. PubMed ID: 15237068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy.
    Nicolucci A; Rossi MC; D'Ostilio D; Delbaere A; de Portu S; Roze S
    Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):707-715. PubMed ID: 29753586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.